Ehrlichia Canis/Anaplasma Phagocytophilum: What Do We Do with a Positive? Stephen C

Ehrlichia Canis/Anaplasma Phagocytophilum: What Do We Do with a Positive? Stephen C

Ehrlichia canis/Anaplasma phagocytophilum: What do we do with a positive? Stephen C. Barr BVSc MVS PhD DACVIM College of Veterinary Medicine Cornell University Ithaca, NY. INTRODUCTION • Tick-borne diseases of dogs and cats causing vasculitis leading to multisystemic dysfunction often characterized by thrombocytopenia and hyperglobulinemia. • Recently reclassified – moved from the family Rickettsiaceae to the Anaplasmataceae. OVERVIEW OF ETIOLOGIC AGENTS • 3 pathogenic genera: Ehrlichia, Anaplasma, and Neorickettsia; we are concerned here with the first 2. • Ehrlichia spp. – divided into 3 groups:- o E. canis – intracyctoplasmic morulae found in circulating leukocytes. o E. chaffeensis – like E. canis, found in mononuclear cells; mainly a human pathogen but can causes disease in dog. o E. ewingii – canine granulocytic ehrlichiosis; like A. phagocytophila, infects granulocytic cells in dogs, but differs in geographic distribution (mainly found in southeastern and south-central USA). • Anaplasma spp. – 2 organisms of importance:- o A. phagocytophila – previously E. equi, E. phagocytophila, and HGE; infects mainly horses; infects granulocytic cells of dogs; serologic cross reactivity occurs with other Anaplasma spp. but uncommon with Ehrlichia spp.; same distribution as Lyme dz (same tick vector) - northeastern and upper Midwestern states, and California. No serologic cross reactivity with Borrelia, Bartonella or Rickettsia rickettsii. o A. platys – previously E. platys; tropism for platelets; does not share serologic cross reactivity with E. canis. In this presentation, we will focus on E. canis and A. phagocytophilum. PATHOGENESIS Ehrlichia canis – Canine monocytotrophic ehrlichiosis. • Rhipicephalus sanguineus (brown dog tick) and occasionally Dermacentor variabilis transmits disease to dogs in saliva. • Incubation period – 1 to 3 weeks. • Severity and outcome of disease depends on infecting strain and dose of inoculum; German shepherd dogs seem more clinically affected • After infection – organisms multiply in macrophages then spread throughout hose:- • 3 stages of disease:- o Acute – spreads from bite site to the spleen, liver, and lymph nodes (causes organomegaly); then subclinical with mild thrombocytopenia; mainly endothelial cells affected; vasculitis; anti-platelet antibodies exacerbates thrombocytopenia; variable leukopenia; mild anemia; severity depends on organism. o Subclinical – organism persists; antibody response increases (hyperglobulinemia); thrombocytopenia persists. o Chronic – impaired bone marrow production (platelets, erythroid suppression); marrow hypercellular with plasma cells. • Multisystemic disease – including bleeding tendencies (thrombocytopenia and vasculitis), lymphadenopathy, splenomegaly, CNS, ocular (anterior uveitis), and lung. Anaplasma phagocytophilum – Canine granulocytic anaplasmosis. • Ixodes spp (I. scapularis in northeast, I. pacificus in California). transmit Dz in saliva • Incubation period – 1to 2 weeks (much shorter than for Lyme disease). • Reservoir hosts - white-footed mouse, chipmunks, wood rats, voles, and white-tailed deer; various bird species are also implicated in spread of disease. • After infection, organism binds and enters mainly neutrophils – multiply (morula) – rupture cell to release more organisms which infect more cells. • How organisms cause disease is not known; after ~ 10 days of infection, cellular and humoral immune mechanisms control infection. • Clinical findings are virtually always associated with acute disease period during the bacteremic phase – chronic disease has not been reported. • Mild illness typified by fever, lethargy and thrombocytopenia; polyarthritis occurs but rare in comparison to infection with E. ewingii; most dogs present in the spring, early summer and again in the fall. CLINICAL SIGNS Ehrlichia canis • Duration of clinical signs from initial acute illness to presentation – usually > 2 months. Acute • Bleeding diatheses – resulting in the development of petechia on mucous membranes (conjunctiva, skin), epistaxis, retinal hemorrhage due to thrombocytopenia and vasculitis • Fever – with depression, anorexia, weight loss. • Generalized lymphadenopathy/splenomegaly (in about 25% of cases). • Ticks – found in 40% of cases. • Respiratory – dyspnea (even cyanosis) and increased bronchovesicular sounds. • Diffuse CNS disease – meningitis (seizures, stupor, ataxia, vestibular dysfunction, cerebellar dysfunction, anisocoria). • Generalized or local hyperesthesia. • Polyarthritis can occur but is rare in E. canis infections – much more common in E. ewingii and A. phagocytophilum. • Most dogs recover without treatment – then enter a subclinical state. Chronic • Spontaneous bleeding, anemia, and generalized lymphadenopathy. • Scrotal and limb edema. • Splenomegaly, hepatomegaly. • Uveitis, hyphema, retinal hemorrhages and detachment with blindness, corneal edema. • Seizures – rare. Anaplasma phagocytophilum • Middle aged to older dogs are more likely diagnosed with the disease. • Most dogs present in the spring, early summer and again in the fall. • Mild illness typified by fever, lethargy, depression, anorexia. • Generalized musculoskeletal pain (reluctance to move, stiff, lameness) – 50% of dogs. • Actual joint pain is found in fewer than 10% of cases. • Very rarely – lymphadenopathy, splenomegaly, hepatomegaly, or CNS signs. • Although thrombocytopenia occurs, bleeding diatheses do not (clinically inapparent). • Dogs are susceptible to reinfection (with 5 mths or more between infections). • Serum antibody levels revert to negative levels by 7 to 8 mths post-treatment. • Chronic carrier state may exist although asymptomatic – none to date show chronic Dz. • Unknown if treatment removes carrier status. • Dogs co-infected with A. phagocytophilum and Borrelia (Lyme disease) will have more severe disease. DIAGNOSIS Ehrlichia canis Acute • CBC – thrombocytopenia (before onset of clinical signs), anemia, leukopenia (due to lymphopenia and eosinopenia), leukocytosis and monocytosis (as disease becomes more chronic); morulae (intracytoplasmic inclusions in leukocytes) are rare. • Mild increases in ALT, ALP, BUN, creatinine, and total bilirubin (rare). • Hyperglobulinemia – progressively increases 1–3 weeks post-infection. • Hypoalbuminemia – usually from renal loss. • Proteinuria – with or without azotemia. Chronic • CBC – Pancytopenia typical; monocytosis and lymphocytosis may be present. • Hyperglobulinemia – size of globulin increase correlates with duration of infection; usually polyclonal gammopathy, but monoclonal (IgG) gammopathies occur. • Hypoalbuminemia. • Elevated BUN and creatinine – glomerulonephritis and renal interstitial plasmacytosis. Serology • Indirect FA – positive by 7 days post-infection (some not until 4 wks PI); most clinically useful and reliable method; highly sensitive – poor specificity with cross-reactivity with E. chaffeensis and E. ewingii (not problems in the northeast) but not A. phagocytophilum (in A. phagocytophilum IFA, slight cross-reactivity with E. canis serum). • Titers usually 1:80 are diagnostic; paired titers recommended as single titer can reflect past infection; titer progressively declines over 6 to 9 months after treatment. high seroprevalence compared to disease prevalence. • Canine Snap® 3 and 4Dx Diagnostic Test (IDEXX Laboratories, Westbrook, ME) – an in-house snap test which tests for antibodies against Lyme disease and E. canis, and heartworm antigen (4D included A. phagocytophilum); detects positive titers to E. canis at an equivalent IFA titer of > 1:500; sensitivity of 95%; specificity of 100% (according to manufacturer); also detects antibodies against E. chaffeensis but not E. ewingii; as with any serologic test, predictive value also depends not only on sensitivity and specificity but also prevalence; in low prevalence areas, likely to get a high false positive rate; could get false positives by reactions to non-pathogenics; confirm +ve test with IFA. • Western Blotting – may be used to differentiate mixed infection. • PCR – proving to be very sensitive in early detection of experimental infections (positive as early as 4 to 10 days PI) but sensitivity (using whole blood samples) in naturally infected cases not as clear cut; poor correlation with IFA in some studies; should be used in conjunction with serology to detect early cases; analysis of samples other than blood (joint fluid, CSF, aqueous humor, splenic aspirates) may be more clinically applicable. Anaplasma phagocytophilum • Most reported cases have been found by finding morulae in neutrophils on the CBC; however, more and more cases are being diagnosed in asymptomatic dogs using the Snap® 4Dx Diagnostic Test (IDEXX Laboratories, Westbrook, ME). • Up to ~40% of neutrophils can contain morulae (are present for 5 to 9 days experimentally); about 80% have mild thrombocytopenia and lymphopenia, and most have eosinopenia (but not neutrophilia); some have mild anemia and hypoalbuminemia. Serology • Sero-conversion (using indirect IFA) occurs about 2 to 5 days after appearance of morulae in blood, and titers remain detectable for about 8 months after acute infection. • Need paired samples 2 to 3 weeks apart to show 4 fold increase in titer because 40% of acutely ill morulae-positive dogs can be sero-negative at presentation; low titers may be because of a previous infection. • Serologic cross-reaction does occur with other Anaplasma spp. and E. canis (although mild) but becomes less cross-reactive during convalescences; no cross- reactions

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us